Please login to the form below

Not currently logged in
Email:
Password:

EMA widens access to EudraGMP database

The European Medicines Agency has increased access to its EudraGMP database, which keeps track of manufacturing inspections from regulatory authorities, to the general public

The European Medicines Agency (EMA) has launched a new version of its EudraGMP database, increasing access to the general public.

The database keeps track of data on all manufacturers of human and animal medicines located in the European Economic Area (EEA) – the EU nations plus Norway, Iceland and Liechtenstein – as well as any information collected by European regulatory authorities about manufacturers from outside the region.

Information contained in the database includes manufacturing and import authorisations and inspections from regulatory authorities, and the registration of Good Manufacturing Practice (GMP) certificates.

The move follows a commitment to greater openness and transparency given by the EMA in December last year, with an initial policy to disclose documents in response to written requests.

Earlier in 2010, the European Parliament had also voted to improve patient access to health and medicines information as part of the EC's 'pharmaceutical package'.

According to the EMA, opening up the EudraGMP in such a way will offer several benefits, including: improving the sharing of information between regulators and industry; eliminating the need for industry to submit applications in paper form; and helping the EMA share information with regulatory authorities elsewhere in the world.

7th February 2011

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dovetail

We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...

Latest intelligence

DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...

Infographics